Elias Sarkis
Child & Adolescent Psychiatry · Gainesville, FLNPI 1285749283
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $117,377 of the $168,625 with a category attached, or 69.6%. 31 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 53.8% of the total. Among child & adolescent psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 787 payments — averaging $214.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$91K
- Ironshore Pharmaceuticals Inc.$16K
- Johnson & Johnson$12K
- Teva Pharmaceuticals USA, Inc.$11K
- Otsuka America Pharmaceutical, Inc.$10K
- Adlon Therapeutics L.p.$9K
- plus $22K from 25 others
Across 988 payments — averaging $3948.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acadia Pharmaceuticals Inc$647K
- Boehringer Ingelheim$497K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$351K
- Janssen Research & Development, LLC$321K
- AbbVie$280K
- Indivior Inc.$273K
- plus $1.5M from 21 others
What the payments were for
- Consulting fees$17,23510%
- Speaking & faculty fees$117,37770%
- Travel & lodging$17,72111%
- Food & beverage$16,24510%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 148 | $90,670 |
| Ironshore Pharmaceuticals Inc. | 79 | $15,702 |
| Johnson & Johnson | 63 | $11,797 |
| Teva Pharmaceuticals USA, Inc. | 38 | $10,694 |
| Otsuka America Pharmaceutical, Inc. | 41 | $9,649 |
| Adlon Therapeutics L.p. | 5 | $8,533 |
| AbbVie(2 entities) | 149 | $8,454 |
| Eisai Inc. | 16 | $6,293 |
| Pfizer | 6 | $1,670 |
| Neos Therapeutics, LP | 57 | $1,058 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $657 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $547 |
| Axsome Therapeutics, Inc. | 10 | $437 |
| Alkermes, Inc. | 16 | $425 |
| Corium, LLC | 8 | $343 |
| Bausch Health US, LLC | 19 | $302 |
| Lundbeck LLC | 14 | $230 |
| Neurocrine Biosciences, Inc. | 8 | $203 |
| Jazz Pharmaceuticals Inc. | 12 | $192 |
| Noven Therapeutics, LLC | 9 | $176 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $132 |
| Vanda Pharmaceuticals Inc. | 6 | $128 |
| Tris Pharma Inc | 5 | $76 |
| Avanir Pharmaceuticals, Inc. | 4 | $67 |
| Arbor Pharmaceuticals, Inc. | 4 | $52 |
| Biogen | 2 | $37 |
| Alfasigma USA, Inc. | 2 | $24 |
| Shire North American Group Inc | 2 | $23 |
| Noven Pharmaceuticals, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$88,008
- Jornay PM 20mg capsules (Bottle of 100)$13,320
- SPRAVATO$10,794
- AUSTEDO$10,180
- REXULTI$8,865
- ADHANSIA XR$8,500
- Dayvigo$6,032
- VRAYLAR$5,940
- GEODON$1,524
- Azstarys$245
- CAPLYTA$123
- Cotempla XR-ODT$122
- Auvelity$110
How this compares
$168,625 in reported general payments places this provider in the 95th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine Sulfate ErDextroamphetamine Sulfate | 12 | $1,493 |
| Gabapentin | 34 | $1,326 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $1,202 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 43 | $1,105 |
| Methylphenidate ErMethylphenidate Hcl | 19 | $789 |
| Bupropion XlBupropion Hcl | 37 | $721 |
| Clonazepam | 68 | $608 |
| Ziprasidone Hcl | 12 | $562 |
| Lorazepam | 44 | $505 |
| Risperidone | 24 | $497 |
| Duloxetine Hcl | 27 | $384 |
| Fluoxetine Hcl | 13 | $329 |
| Hydroxyzine Hcl | 12 | $267 |
| Escitalopram Oxalate | 29 | $238 |
| Diazepam | 18 | $198 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Gainesville
- Muhammad SajidGainesville$5K
- Ayesha LallGainesville$4K
- Amparo Benitez-BroomeGainesville$2K
- Craig KuninsGulfport$265K
- Jeffrey AlvaroSt Petersburg$87K
- Rosa Negron MunozLakeland$39K
- Sean HoranMiami$17K
- Rachel AgustinesLargo$16K
- Carlos BorgeSarasota$15K
- Justin SpoonerPonte Vedra Beach$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.